Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practice

por Bouwer, Nathalie I., Jager, Agnes, Liesting, Crista, Kofflard, Marcel J.M., Brugts, Jasper J., Kitzen, Jos J.E.M., Boersma, Eric, Levin, Mark-David
Publicado 2020

2D-echocardiography vs cardiac MRI strain: a prospective cohort study in patients with HER2-positive breast cancer undergoing trastuzumab

por Bouwer, Nathalie I., Liesting, Crista, Kofflard, Marcel J. M., Brugts, Jasper J., Kock, Marc C. J., Kitzen, Jos J. E. M., Levin, Mark-David, Boersma, Eric
Publicado 2021

NT-proBNP correlates with LVEF decline in HER2-positive breast cancer patients treated with trastuzumab

por Bouwer, Nathalie I., Liesting, Crista, Kofflard, Marcel J. M., Sprangers-van Campen, Sylvia M., Brugts, Jasper J., Kitzen, Jos J. E. M., Fouraux, Michael A., Levin, Mark-David, Boersma, Eric
Publicado 2019

Risk of cancer after ST-segment-elevation myocardial infarction

por Leening, Maarten J. G., Bouwer, Nathalie I., Ikram, M. Arfan, Kavousi, Maryam, Ruiter, Rikje, Boersma, Eric, van den Bos, Ewout-Jan, Weevers, Auke P. J. D., Deckers, Jaap W., Levin, Mark-David
Publicado 2023

The effect of trastuzumab on cardiac function in patients with HER2‐positive metastatic breast cancer and reduced baseline left ventricular ejection fraction

por Bouwer, Nathalie I., Steenbruggen, Tessa G., Rier, Hánah N., Kitzen, Jos J. E. M., Smorenburg, Carolien H., van Bekkum, Marlies L., de Jong, Paul C., Drooger, Jan C., Holterhues, Cynthia, Kofflard, Marcel J. M., Boersma, Eric, Sonke, Gabe S., Levin, Mark‐David, Jager, Agnes
Publicado 2022